BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zaraket H, Hurt AC, Clinch B, Barr I, Lee N. Burden of influenza B virus infection and considerations for clinical management. Antiviral Res 2021;185:104970. [PMID: 33159999 DOI: 10.1016/j.antiviral.2020.104970] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Wagatsuma K, Saito R, Chon I, Phyu WW, Fujio K, Kawashima T, Sato I, Saito T, Minato M, Kodo N, Suzuki E, Ono Y, Masaki H, Shirahige Y, Kitano A, Hamabata H, Yuyang S, Jiaming L, Watanabe H. Duration of fever and symptoms in influenza-infected children treated with baloxavir marboxil during the 2019–2020 season in Japan and detection of influenza virus with the PA E23K substitution. Antiviral Research 2022;201:105310. [DOI: 10.1016/j.antiviral.2022.105310] [Reference Citation Analysis]
2 Xu D, Zheng QC. Theoretical investigations on the effects of mutations in important residues of NS1B on its RNA-binding using molecular dynamics simulations. Comput Biol Med 2022;145:105412. [PMID: 35344866 DOI: 10.1016/j.compbiomed.2022.105412] [Reference Citation Analysis]
3 Koutsakos M, Kent SJ. Influenza B viruses: underestimated and overlooked. Microbiol Aust 2021;42:110. [DOI: 10.1071/ma21033] [Reference Citation Analysis]
4 Rattan A, White CL, Nelson S, Eismann M, Padilla-quirarte H, Glover MA, Dileepan T, Marathe BM, Govorkova EA, Webby RJ, Richards KA, Sant AJ. Development of a Mouse Model to Explore CD4 T Cell Specificity, Phenotype, and Recruitment to the Lung after Influenza B Infection. Pathogens 2022;11:251. [DOI: 10.3390/pathogens11020251] [Reference Citation Analysis]
5 Holmes EC, Hurt AC, Dobbie Z, Clinch B, Oxford JS, Piedra PA. Understanding the Impact of Resistance to Influenza Antivirals. Clin Microbiol Rev 2021;34:e00224-20. [PMID: 33568554 DOI: 10.1128/CMR.00224-20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]